Many individuals struggling with weight also report problematic drinking patterns, creating a situation where both conditions reinforce each other
GLP-1 receptor agonist medications (including semaglutide, dulaglutide, liraglutide, exenatide, and lixisenatide) are typically considered for type 2 diabetes when: Triple therapy with other diabetes medications is not effective, not tolerated, or contraindicated The person has a BMI 35 kg/m (adjusted by 2.5 kg/m for people from South Asian, Chinese, other Asian, Black African, or African-Caribbean backgrounds) and specific weight-related psychological or medical problems A lower BMI threshold may be appropriate if weight loss would benefit other obesity-related comorbidities Insulin would not be appropriate or acceptable to the person Treatment is usually continued only if there is a beneficial metabolic response (reduction in HbA1c and weight) after 6 months
Yes medications are shipped directly to your home for convenience
Womans World wants to hear YOUR experiences with Mochi, or your experiences with prescription weight loss or telehealth in general
Prebiotics Inulin, fructooligosaccharides 20 (FOS), and galactooligosaccharides 21 (GOS) are prebiotic fibers that feed gut bacteria linked to higher GLP-1 levels
